Patients with AD treated with dupilumab have a lower risk of various infections than those treated with methotrexate or cyclosporine.

Dupilumab in combination with other biologic agents is safe and effective for treating various chronic inflammatory conditions.

Patients with atopic dermatitis experienced improvements in severity with 16 weeks of tralokinumab despite the number of ...

The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...

Considering dual biologic therapy for psoriasis or eczema? Get a firsthand account of navigating insurance, potential side effects, and treatment outcomes.

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

Recent FDA decisions added new options for dermatologists involved in treating patients with psoriasis, bullous pemphigoid and advanced skin cancer. This FDA recap highlights recent approvals in April ...

Medicare may cover epidural steroid injections for pain management when the pain is severe, caused by specific conditions, and lasts over 4 weeks despite other treatment.

Discover a study where results suggest a statistically significant association between dupilumab and psoriasis, although the clinical impact may be limited.

The FDA has approved a 200 mg/mL autoinjector of belimumab (Benlysta) for at-home subcutaneous use in children aged 5 years and older with active lupus nephritis receiving standard therapy-marking the ...

Children with diabetes who inhaled their mealtime doses of insulin did just as well as those who injected insulin under the skin, researchers reported at the American Diabetes Association ...